Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/2/2011

nine months ended September 30, 2011 and 2010 because their effect would be anti-dilutive.ONYX PHARMACEUTICALS, INC.CALCULATION OF REVENUE FROM COLLABORATION AGREEMENT(In thousands, unaudited)Three Months EndedNine Months EndedSeptember 30, September 30, 2011201020112010Nexavar product revenue, net (as recorded by Bayer)

$ 250,340$ 226,181$ 731,472$ 676,665Nexavar revenue subject to profit sharing (as recorded by Bayer)

$ 208,683$ 191,553$ 608,453$ 580,399Combined cost of goods sold, distribution, selling, general and administrative expenses

77,23478,464240,774237,184Combined collaboration commercial profit

$ 131,449$ 113,089$ 367,679$ 343,215Onyx's share of collaboration commercial profit

$   65,725$   56,545$ 183,840$ 171,607Reimbursement of Onyx's shared marketing expenses

6,4004,72717,69117,026Royalty revenue

2,9162,4248,6116,739Revenue from collaboration agreement

$   75,041$   63,696$ 210,142$ 195,372ONYX PHARMACEUTICALS, INC.RECONCILIATION OF GAAP TO NON-GAAP NET INCOME (LOSS)(In thousands, except per share amounts)(unaudited)Three Months EndedNine Months EndedSeptember 30, September 30, 2011201020112010GAAP net (loss) / income$(36,860)$41,500$(140,565)$(67,726)Non-GAAP adjustments:Contingent consideration5,9455,62223,195101,107Employee stock-based compensation8,6735,87422,37316,592Imputed interest related to the convertible senior notes due 20162,6432,2927,5876,671Advance funding to S*BIO--12,666-Impairment of equity investment in S*BIO--3,000-Lease termination exit costs130-10,857-Non-GAAP net (loss) / income (5)$(19,469)$55,288$  (60,887)$  56,644Computation of non-GAAP diluted net (loss) / incomeNon-GAAP net (loss) / income (5)$(19,469)$55,288$  (60,887)$  56,644Add:Interest and issuance costs related to dilutive convertible senior notes (6)-2,532--Non-GAAP net (loss) / income - diluted (5)$(19,469)$57,820$  (60,887)$  56,644Comput
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  Northstar Global Business ... Trust Company (DTC) has made their final decision ... on the Company,s stock effective December 15, 2014, ... stock for depository and book entry transfer services. All ... is now once again fully "DTC Eligible", and ...
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. (NYSE ... closing of its offering of $125 million aggregate principal ... "Notes").  The Notes were offered and sold only to ... Securities Act of 1933, as amended (the "Securities Act"). ... rate of 3.75% per year, payable semiannually in arrears ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/vt6973/mems_gyroscopes ) ... Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... a lot of progress in the past few ... accepted in high-reliability environments, and are even starting ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... April 14, 2011 Carl Zeiss Meditec, Inc., ... at the 79th Annual Meeting of the American ... Based on the breakthrough OPMI® Pentero surgical visualization ... new features and customer benefits such as: ...
... 2011 Varian Medical Systems (NYSE: VAR ... endometrial cancer patients after a hysterectomy. The Capri™ applicator, ... better sculpt the radiotherapy dose, is being exhibited this ... in San Diego. The applicator can also be used ...
Cached Medicine Technology:PENTERO 900: Elevating Excellence in Microsurgery to a New Level 2PENTERO 900: Elevating Excellence in Microsurgery to a New Level 3New Brachytherapy Applicator for Endometrial Cancer Patients Introduced at ABS 2011 by Varian Medical Systems 2
(Date:12/17/2014)... In its comprehensive analysis of medical claims, ... division have recently identified out-of-network and medical necessity reviews ... achieved on behalf of employer-clients. , The third ... to Argus each year, with a total of $6.4 ... Doney, Cypress president and CEO, these in-depth medical claim ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... world of infectious diseases, one worrisome phenomenon is when an ... The process -- known as zoonosis -- is not uncommon ... signs that an animal-borne disease might make inroads into the ... a development -- and the culprits in this case were ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... to improve overall health, but a growing body of evidence ... new review finds. In fact, the benefits were similar ... lead researcher Paula Chu, a doctoral candidate at Harvard University,s ... clinical trials, found that people randomly assigned to take yoga ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), ... a new study providing evidence on the impact of ... children. , Sufficient enough evidence already exists showing a ... juice drinks, with the onset of tooth decay. One ... listed as 100% fruit juice, meaning it is completely ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... study should reassure the millions of American women who have ... cancer. "There is no association between migraine and breast ... of medicine at Harvard Medical School. "There is no positive ... is no protective effect either." About 18 percent of ...
Breaking Medicine News(10 mins):Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... fundamental change in the U.S. health care system , ... Washington, D.C. ... Challenge (DTCC) released today by the American Pharmacists Association (APhA) ... people with diabetes manage their disease and reduce health care costs., , ...
... evolving approach to treatment of co-morbiditiesWOONSOCKET, R.I., April 6 ... CVS ) published today in the April 2009 issue ... found that over a two-and-a-half year period ending in ... blood pressure, high cholesterol and diabetes among children increased ...
... high-fiber, low-sugar regimen reduced risk factors , , MONDAY, ... reducing sugar consumption can help reduce type 2 diabetes ... , "Latino children are more insulin-resistant and thus more ... counterparts. To date, only a few studies have examined ...
... getting same screenings as healthy folks, , , MONDAY, April 6 ... undergo a colonoscopy only if they expect to live ... seriously ill elderly men in the United States are being ... The finding specifically reflects the experiences of men seeking care ...
... Study finds a ,pathway of persistence, throughout life , , MONDAY, ... problems may be at increased risk for suicide when they,re ... included 5,302 people who were born in 1981 and followed ... (24 males, 16 females). Of those, 13 males and two ...
... play a part , , MONDAY, April 6 (HealthDay News) -- Small ... -- in other words, those who have more difficulty delaying gratification ... , The same seems true of young children who ... unclear whether these findings, from two studies published in the April ...
Cached Medicine News:Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 2Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 3Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 4Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 5Health News:CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents 2Health News:CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents 3Health News:Dietary Changes Shield Latino Teens From Diabetes 2Health News:Colon Screenings Don't Follow Guidelines, Study Suggests 2Health News:Colon Screenings Don't Follow Guidelines, Study Suggests 3Health News:Early Psychiatric Issues May Predict Suicide in Boys 2Health News:Kids Who Lack Self-Control May Be Prone to Weight Gain 2Health News:Kids Who Lack Self-Control May Be Prone to Weight Gain 3
The lower body blanket is designed to be used primarily during surgery on the upper half of the body....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
... wide variety of financing options including direct ... a direct lender to dentists and physicians ... proven invaluable to our clients. Our customers ... for financial services because we understand their ...
Medicine Products: